CN100536895C - Formulaion in traditional chinese medical prescription for treating waist and neck hyperosteogeny - Google Patents
Formulaion in traditional chinese medical prescription for treating waist and neck hyperosteogeny Download PDFInfo
- Publication number
- CN100536895C CN100536895C CNB2006100210541A CN200610021054A CN100536895C CN 100536895 C CN100536895 C CN 100536895C CN B2006100210541 A CNB2006100210541 A CN B2006100210541A CN 200610021054 A CN200610021054 A CN 200610021054A CN 100536895 C CN100536895 C CN 100536895C
- Authority
- CN
- China
- Prior art keywords
- radix
- hyperosteogeny
- chinese medicine
- root
- rhizoma zingiberis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to a Chinese medicine compound mixture for hyperosteogeny to be taken orally, characterised in that the Chinese medicine compound mixture is formed by the following raw medicine by weight ratio: 16-24 of angelica, 18-25 of frankincense, 10-18 of myrrh, 22-28 of safflower, 26-32 of peach kernel, 16-22 of brazilwood, 10-18 of radix paeoniae rubra, 28-36 of gragons blood, 16-22 of dendrobium stem, 22-28 of root of drynaria forunei(Kunze)J.Sm, 10-18 of radix gentianae macrophyllae, 16-24 of lindera root, 16-24 of honeysuckle flower, 16-24 of chrysanthemum, 12-16 of frutus aurantii immaturus, 16-19 of notoginseng, 22-28 of rantong, 48-52 of white peony root, 10-16 of pawpaw, 10-16 of fasciolopsis buski, 10-16 of leatherleaf milletia, 15-18 of clematis root, 15-20 kudzuvine root and 10-16 of glycyrrhiza. The Chinese medicine compound mixture is safe and highly effective, at the same time has effects of stimulating circulation to end stasis, antiinflammation, dispelling the wind, removing the cold and expelling the black for the new, to thoroughly heal the hyperosteogeny of waist and cervix.
Description
Technical field:
The invention belongs to tcm field.Specifically, the present invention relates to treat the Chinese medicine for oral administration mixture of hyperosteogeny.Chinese medicine for oral administration mixture of the present invention can be used for thoroughly curing the hyperosteogeny of waist cervical region.
Background technology:
Theory of Chinese medical science thinks that hyperosteogeny and caused by liver and kidney deficiency, wound are strained, affection of exogenous wind-cold, and phlegm resistance etc. are relevant.
1) caused by liver and kidney deficiency: theory of Chinese medical science is thought " kidney controlling essence storage, main bone give birth to marrow ", and then body is strong as if the kidney essense abundance, and skeleton profile and internal structure are normal, and can endure hardships and involve general trauma.And " liver storing blood, the sharp joint of main muscle Shugu ", the liver blood abundance, then the muscle arteries and veins is powerful, quietly protects all bones, improves bone marrow; Moving then retrain all bones, exempt to cause over-activity, prevent dislocation; if deficiency of kidney-essence, deficiency of liver-blood; then skeleton development is unusual, not hard, flourish weary source, the promptly unable protection skeleton of supporting of more double muscles; the bone marrow of supplementing nutrition; can not retrain all bones again, prevent the dislocation, for a long time it; the joint can suffer damage and too fast appearance regression too early in active procedure repeatedly gradually.
2) wound and strain: momentaryly bear super-strength external force, comprise and turn round, frustrate, hit, fall etc., or bear super-strength external force for a long time and strain, as work of taking incorrect posture constant tension under the particular state etc., can cause the acute or chronic injury in joint, can cause that the most concentrated stressed local joint generation QI and blood is disorderly contrary, severe patient can cause muscle to decrease bone injury, blood follows and does not flow normal road and overflow outside arteries and veins, the formation blood stasis stagnates, and causes joint skeleton structural damage, loses nourishing, for a long time it, degeneration can occur.
3) wind-cold damp pathogen is invaded: be affected by the cold, catch a cold, occupy for a long time dark and damp ground etc., exopathogen is taken advantage of a loophole and is invaded flesh table meridians, the visitor in the joint, muscles and bones, can cause the QI-blood circulation retardance, passages through which vital energy circulates resistance numbness, muscles and bones mistake is supported, and gradually becomes rheumatism involving the bone.
4) phlegm resistance: " fertile people's excessive phlegm wet ", so fat people easily suffers from primary disease, the body of obesity, the wet Sheng of many yang deficiency wets and gathers into expectorant, with through multiple abscess in joint part; Fat again people can increase the weight of the heavy burden in joint, and the two all can cause, and local joint blood fortune is not smooth, muscles and bones mistake is supported, and then becomes numbness for a long time.
Bone matrix hyperplasia belongs to the traditional Chinese medical science " arthromyodynia " category, also claims " rheumatism involving the bone ", does not also treat this sick specific drug at present.And hyperosteogeny is the commonly encountered diseases of middle-aged and elderly people, frequently-occurring disease, with advancing age, the joint part of human body degenerative change occurred and has formed hyperosteogeny, especially positions such as cervical vertebra, lumbar vertebra, knee joint, heel are because activity is many, it is big to bear a heavy burden, and the muscle ligament traction force strong so also be the most site of pathological change of seeing more.Wind, wet, cold three evil human bodies of invading are that important risk factor initial symptoms is slight, and the person of being in a bad way moving difficulty can occur and can't take care of oneself.Bone matrix hyperplasia patient's main clinical manifestation has arthralgia, swelling and three aspects of function limitation.
At present, the medicine of treatment arthromyodynia is a lot of really, and be divided into and take orally and two kinds of externals, but present specific drug of also not treating hyperosteogeny.Oral medicine is because user to the losing control of of the medicine property of medicine and dosage, causes individual drug excessive to the side effect of human body, in the time of the treatment hyperosteogeny, and causes the corresponding pathological changes of other organs of human body.The medicine for external use therapeutic effect is also not obvious, and the effect that will only play relief of symptoms that has can not fundamentally be dealt with problems, though the medicine that has has certain curative effect, the course of treatment is long, and cure rate is low.
Therefore, this area presses for the new Chinese medicine preparation of exploitation, explores efficient, the safe Chinese patent medicine that can thoroughly cure hyperosteogeny of development.
Summary of the invention:
The invention provides a kind of efficient, the safe Chinese patent medicine for oral administration that can cure hyperosteogeny.
Technical solution of the present invention is: a kind of Chinese medicine for the treatment of hyperosteogeny is characterized in that being made of according to weight ratio following Chinese medicine: Radix Angelicae Sinensis 16～24, Olibanum 18～25, Myrrha 10～18, Flos Carthami 22～28, Semen Persicae 26～32, Lignum Sappan 16～22, Radix Paeoniae Rubra 10～18, Sanguis Draxonis 28～36, Herba Dendrobii 16～22, monkey Rhizoma Zingiberis Recens 22～28, Radix Gentianae Macrophyllae 10～18, the Radix Linderae 16～24, Flos Lonicerae 16～24, Flos Chrysanthemi 16～24, Fructus Aurantii Immaturus 12～16, Radix Notoginseng 16～19, burnt copper 22～28, the Radix Paeoniae Alba 48～52, Fructus Chaenomelis 10～16, Rhizoma Zingiberis Recens worm 10～16, Caulis Spatholobi 10～16, the Radix Clematidis 15～18, Radix Puerariae 15～20, Radix Glycyrrhizae 10～16.
Its best Chinese medicine constituent ratio: Radix Angelicae Sinensis 19, Olibanum 24, Myrrha 12, Flos Carthami 26, Semen Persicae 28, Lignum Sappan 18, Radix Paeoniae Rubra 16, Sanguis Draxonis 32, Herba Dendrobii 18, monkey Rhizoma Zingiberis Recens 26, Radix Gentianae Macrophyllae 16, the Radix Linderae 16, Flos Lonicerae 18, Flos Chrysanthemi 22, Fructus Aurantii Immaturus 15, Radix Notoginseng 18, burnt copper 24, the Radix Paeoniae Alba 49, Fructus Chaenomelis 13, Rhizoma Zingiberis Recens worm 15, Caulis Spatholobi 15, the Radix Clematidis 17, Radix Puerariae 16, Radix Glycyrrhizae 12.
The present invention is a kind of Chinese medicine for oral administration mixture of efficient, safe treatment hyperosteogeny, and this medical instrument has activating blood circulation to dissipate blood stasis, antiinflammatory, dispels the wind and remove effect cold and the black granulation promoting of dispelling, thereby can thoroughly treat hyperosteogeny.It is big that this medicine has overcome oral medicine side effect for a long time, the unfavorable shortcoming of medicine for external use drug effect.This medicine mainly is applicable to the hyperosteogeny of waist, cervical region.Using method of the present invention is simple, no pain; Short treating period, instant effect has no side effect, and through clinical verification, effective percentage reaches 100%, and cure rate reaches more than 95%.
The specific embodiment:
1) the present invention is developed into powder with herb mixture through pulverizer, mix wine then and swallow, the morning, noon and afternoon each once, about at every turn 20g.
2) the present invention is developed into powder with herb mixture through pulverizer, mix boiled water then and swallow, the morning, noon and afternoon each once, about at every turn 20g.
3) the present invention is developed into powder with herb mixture through pulverizer, makes honeyed pill with Mel, the morning, noon and afternoon each once, each about 15～25.
4) the present invention is developed into powder with herb mixture through pulverizer, extracts its effective ingredient, makes sugar coated tablet or compound capsule then.
Embodiment:
Example 1:
Radix Angelicae Sinensis 19, Olibanum 24, Myrrha 12, Flos Carthami 26, Semen Persicae 28, Lignum Sappan 18, Radix Paeoniae Rubra 16, Sanguis Draxonis 32, Herba Dendrobii 18, monkey Rhizoma Zingiberis Recens 26, Radix Gentianae Macrophyllae 16, the Radix Linderae 16, Flos Lonicerae 18, Flos Chrysanthemi 22, Fructus Aurantii Immaturus 15, Radix Notoginseng 18, burnt copper 24, the Radix Paeoniae Alba 49, Fructus Chaenomelis 13, Rhizoma Zingiberis Recens worm 15, Caulis Spatholobi 15, the Radix Clematidis 17, Radix Puerariae 16, Radix Glycyrrhizae 12.
Above-mentioned medicine is developed into Powdered, mix homogeneously.During use, confirm have hyperosteogeny and wine to swallow through the x mating plate.After taking medicine, adopt the x mating plate to confirm the improvement situation of hyperosteogeny.
Example 2:
Radix Angelicae Sinensis 18, Olibanum 24, Myrrha 12, Flos Carthami 24, Semen Persicae 26, Lignum Sappan 16, Radix Paeoniae Rubra 16, Sanguis Draxonis 26, Herba Dendrobii 16, monkey Rhizoma Zingiberis Recens 24, Radix Gentianae Macrophyllae 16, the Radix Linderae 14, Flos Lonicerae 18, Flos Chrysanthemi 19, Fructus Aurantii Immaturus 16, Radix Notoginseng 18, burnt copper 26, the Radix Paeoniae Alba 50, Fructus Chaenomelis 13, Rhizoma Zingiberis Recens worm 15, Caulis Spatholobi 13, the Radix Clematidis 15, Radix Puerariae 16, Radix Glycyrrhizae 12.
Above-mentioned medicine is developed into Powdered, mix homogeneously.During use, confirm to have hyperosteogeny through the x mating plate equally, with boiled water and even swallowing.After taking medicine, adopt the x mating plate to confirm the improvement situation of hyperosteogeny equally.
1. what certain, the man, 37 years old, lumbago 1 year half, through the check of x mating plate, lumbar vertebra 3-5 joint hyperosteogeny 4*3.6cm take medicine after 4 doses, and the hyperosteogeny complete obiteration is found in the check of x mating plate.
2. Qin, the woman, 53 years old, about 2 years of lumbago, through the check of x mating plate, lumbar vertebra 3-4 joint hyperosteogeny 2*2cm take medicine after 4 doses, and the hyperosteogeny complete obiteration is found in the check of x mating plate.
3. Zeng, the woman, 48 years old, lumbago 3 years, through the check of x mating plate, lumbar vertebra 2-5 joint hyperosteogeny 2*2cm take medicine after 4 doses, and the hyperosteogeny complete obiteration is found in the check of x mating plate.
4. Liu, the man, 66 years old, lumbago 2 years half, through the check of x mating plate, lumbar vertebra 3-5 joint hyperosteogeny 2*3.5cm also accompany intervertebral disk hernia, take medicine after 5 doses, and the hyperosteogeny complete obiteration is found in the check of x mating plate.
5. Liao, the woman, 65 years old, lumbago 3 years, through the check of x mating plate, lumbar vertebra 3-5 joint hyperosteogeny 3.2*2cm also accompany intervertebral disk hernia, take medicine after 4 doses, and the hyperosteogeny complete obiteration is found in the check of x mating plate.
Claims (3)
1. a Chinese medicine for the treatment of hyperosteogeny is characterized in that being made of according to weight ratio following Chinese medicine: Radix Angelicae Sinensis 16～24, Olibanum 18～25, Myrrha 10～18, Flos Carthami 22～28, Semen Persicae 26～32, Lignum Sappan 16～22, Radix Paeoniae Rubra 10～18, Sanguis Draxonis 28～36, Herba Dendrobii 16～22, monkey Rhizoma Zingiberis Recens 22～28, Radix Gentianae Macrophyllae 10～18, the Radix Linderae 16～24, Flos Lonicerae 16～24, Flos Chrysanthemi 16～24, Fructus Aurantii Immaturus 12～16, Radix Notoginseng 16～19, burnt copper 22～28, the Radix Paeoniae Alba 48～52, Fructus Chaenomelis 10～16, Rhizoma Zingiberis Recens worm 10～16, Caulis Spatholobi 10～16, the Radix Clematidis 15～18, Radix Puerariae 15～20, Radix Glycyrrhizae 10～16.
2. the Chinese medicine of treatment hyperosteogeny as claimed in claim 1 is characterized in that being made of according to weight ratio following Chinese medicine: Radix Angelicae Sinensis 19, Olibanum 24, Myrrha 12, Flos Carthami 26, Semen Persicae 28, Lignum Sappan 18, Radix Paeoniae Rubra 16, Sanguis Draxonis 32, Herba Dendrobii 18, monkey Rhizoma Zingiberis Recens 26, Radix Gentianae Macrophyllae 16, the Radix Linderae 16, Flos Lonicerae 18, Flos Chrysanthemi 22, Fructus Aurantii Immaturus 15, Radix Notoginseng 18, burnt copper 24, the Radix Paeoniae Alba 49, Fructus Chaenomelis 13, Rhizoma Zingiberis Recens worm 15, Caulis Spatholobi 15, the Radix Clematidis 17, Radix Puerariae 16, Radix Glycyrrhizae 12.
3. the Chinese medicine of treatment hyperosteogeny as claimed in claim 1 is characterized in that comprising the Chinese medicine that constitutes according to weight ratio, or its honeyed pill, sugar-coated preparation and compound capsule etc.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100210541A CN100536895C (en) | 2006-05-31 | 2006-05-31 | Formulaion in traditional chinese medical prescription for treating waist and neck hyperosteogeny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100210541A CN100536895C (en) | 2006-05-31 | 2006-05-31 | Formulaion in traditional chinese medical prescription for treating waist and neck hyperosteogeny |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101036751A CN101036751A (en) | 2007-09-19 |
| CN100536895C true CN100536895C (en) | 2009-09-09 |
Family
ID=38888059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100210541A Expired - Fee Related CN100536895C (en) | 2006-05-31 | 2006-05-31 | Formulaion in traditional chinese medical prescription for treating waist and neck hyperosteogeny |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100536895C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106266382A (en) * | 2016-08-29 | 2017-01-04 | 马久生 | A kind of Chinese medicine composition treating fracture, bone does not connect |
-
2006
- 2006-05-31 CN CNB2006100210541A patent/CN100536895C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101036751A (en) | 2007-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102488869B (en) | Traditional Chinese medicinal external-use liniment for muscle and bone ache | |
| CN100367985C (en) | Chinese prepared medicine for treating bone pain | |
| CN101015651A (en) | Medicine for treating protrusion of lumbar intervertebral disc | |
| CN103230488B (en) | Traditional Chinese medicine composition for treating lumbar disc herniation, osteoproliferation and cervical spondylosis | |
| CN101919988B (en) | Medicine compound for curing rheumatism rheumatoid arthritis and preparation method thereof | |
| CN103356877A (en) | Traditional Chinese medicine composition for treating orthopedic diseases | |
| CN102166277B (en) | Waist healing pill | |
| CN101524450B (en) | Oral traditional Chinese medicine for setting bones and relieving rigidity of muscles and preparation method thereof | |
| CN102100754A (en) | Chinese medicinal composition for treating osteoproliferation | |
| CN102008610B (en) | Traditional Chinese medicine composition for curing hyperosteogeny | |
| CN101269157B (en) | Method for preparing wine for warming meridian, removing paralysism, releasing tendon, activating collaterals to relieve pain | |
| CN103893380A (en) | Traditional Chinese medicinal preparation for treating vertebral hyperosteogeny | |
| CN103565969A (en) | Traditional Chinese medicine composition for treating soft tissue injury and fracture | |
| CN105288232A (en) | Traditional Chinese medicine capsule for treating rheumatic bone disease and preparing method thereof | |
| CN102048863A (en) | Traditional Chinese medicine for treating lumbar hyperosteogeny | |
| CN101912458B (en) | Medicament for treating protrasion of the lumbar intervertebral disci | |
| CN100536895C (en) | Formulaion in traditional chinese medical prescription for treating waist and neck hyperosteogeny | |
| CN105853969A (en) | Traditional Chinese medicine composition for treating lumbar disc herniation and lumbar spinal stenosis and preparation method thereof | |
| CN106421255B (en) | External Chinese herbal medicine composition and application thereof | |
| CN104606313A (en) | Traditional Chinese medicinal ointment for treating osteoarticular diseases and bone fractures | |
| CN103372187A (en) | Medicine for treating urticaria | |
| CN103083489B (en) | Traditional Chinese medicine wine for treating lumbar spondylosis, cervical spondylosis, early osteoproliferation and old wounds | |
| CN102028768A (en) | Traditional Chinese medicament for treating lumbar canal stenosis | |
| CN102028810B (en) | Traditional Chinese medicine for treating lumbar intervertebral disc protrusion | |
| CN101502598B (en) | Medicament for treating protrusion of lumber vertebral disc and method for preparing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090909 Termination date: 20200531 |